{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:23:14Z","timestamp":1789183394635,"version":"build-2803163510"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fund for Scientific Research","doi-asserted-by":"publisher","award":["FC 50079"],"award-info":[{"award-number":["FC 50079"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011699","name":"Siemens Healthineers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007210","name":"Varian Medical Systems Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ctro.2025.101014","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T21:24:49Z","timestamp":1752614689000},"page":"101014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Radiotherapy boost to the primary tumour in locally advanced rectal cancer: Systematic review of practices and meta-analysis"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0880-9894","authenticated-orcid":false,"given":"Julien","family":"Pierrard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Donnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix","family":"Collard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8426-1379","authenticated-orcid":false,"given":"Genevi\u00e8ve","family":"Van Ooteghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2025.101014_b0005","unstructured":"Ferlay J, et al. Global cancer observatory: cancer today (version 1.1). 2024 21 August 2024]; Available from: https:\/\/gco.iarc.who.int\/today."},{"key":"10.1016\/j.ctro.2025.101014_b0010","unstructured":"Hofheinz RD, et al., Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2025.101014_b0020","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.ctro.2025.101014_b0025","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2468-1253(22)00392-2","article-title":"Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial","volume":"8","author":"Gerard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101014_b0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(15)00467-2","article-title":"Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis","volume":"17","author":"Renehan","year":"2016","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0040","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ijrobp.2020.06.013","article-title":"Efficacy of dose-escalated chemoradiation on complete tumor response in patients with locally advanced rectal cancer (RECTAL-BOOST): a phase 2 randomized controlled trial","volume":"108","author":"Couwenberg","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijrobp.2012.05.017","article-title":"Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy","volume":"85","author":"Appelt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2014.08.035","article-title":"Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis","volume":"113","author":"Burbach","year":"2014","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0055","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ijrobp.2021.09.052","article-title":"Impact of dose-escalated chemoradiation on quality of life in patients with locally advanced rectal cancer: 2-year follow-up of the randomized RECTAL-BOOST trial","volume":"112","author":"Verweij","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2025.101014_b0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2016.07.017","article-title":"International consensus guidelines on clinical target volume delineation in rectal cancer","volume":"120","author":"Valentini","year":"2016","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2025.101014_b0065","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ctro.2025.101014_b0070","series-title":"Systematic reviews: CRD\u2019s guidance for undertaking reviews in healthcare","author":"Dissemination","year":"2009"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0075","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ijrobp.2007.03.046","article-title":"Moderately low alpha\/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy","volume":"69","author":"Suwinski","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s003840050072","article-title":"Pathological features of rectal cancer after preoperative radiochemotherapy","volume":"12","author":"Dworak","year":"1997","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ctro.2025.101014_b0085","unstructured":"Wells GA, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000."},{"issue":"17","key":"10.1016\/j.ctro.2025.101014_b0090","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/sim.1482","article-title":"Improved tests for a random effects meta-regression with a single covariate","volume":"22","author":"Knapp","year":"2003","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3102\/10769986030003261","article-title":"Bias and Efficiency of Meta-Analytic Variance Estimators in the Random-Effects Model","volume":"30","author":"Viechtbauer","year":"2005","journal-title":"J Educ Behav Stat"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jrsm.1316","article-title":"A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses","volume":"10","author":"Langan","year":"2019","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ctro.2025.101014_b0105","doi-asserted-by":"crossref","unstructured":"Borenstein M, et al. Introduction to meta-analysis. 2021: John Wiley & Sons.","DOI":"10.1002\/9781119558378"},{"issue":"11","key":"10.1016\/j.ctro.2025.101014_b0110","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"10","key":"10.1016\/j.ctro.2025.101014_b0115","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","article-title":"Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry","volume":"61","author":"Peters","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.ctro.2025.101014_b0120","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"Peters","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ctro.2025.101014_b0125","series-title":"Doing meta-analysis with R: a hands-on guide","author":"Harrer","year":"2021"},{"issue":"2","key":"10.1016\/j.ctro.2025.101014_b0130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.radonc.2009.08.046","article-title":"MR-guided simultaneous integrated boost in preoperative radiotherapy of locally advanced rectal cancer following neoadjuvant chemotherapy","volume":"93","author":"Seierstad","year":"2009","journal-title":"Radiother Oncol"},{"issue":"16","key":"10.1016\/j.ctro.2025.101014_b0135","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.7150\/jca.21237","article-title":"A phase II trial of preoperative concurrent chemotherapy and dose escalated intensity modulated radiotherapy (IMRT) for locally advanced rectal cancer","volume":"8","author":"Tey","year":"2017","journal-title":"J Cancer"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jmrs.396","article-title":"Developing knowledge-based planning for gynaecological and rectal cancers: a clinical validation of RapidPlan\u2122","volume":"67","author":"Shepherd","year":"2020","journal-title":"J Med Radiat Sci"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13014-023-02353-x","article-title":"THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysis","volume":"18","author":"Chiloiro","year":"2023","journal-title":"Radiat Oncol"},{"issue":"1120","key":"10.1016\/j.ctro.2025.101014_b0150","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200931","article-title":"Sexual organ-sparing with hydrogel spacer injections for rectal cancer radiotherapy: a feasibility pilot study","volume":"94","author":"Achard","year":"2021","journal-title":"Br J Radiol"},{"issue":"8","key":"10.1016\/j.ctro.2025.101014_b0155","first-page":"310","article-title":"Evaluation of three-dimensional conformal radiation therapy in rectal cancer","volume":"20","author":"Al-Khalidi","year":"2022","journal-title":"NeuroQuantology"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0160","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12029-018-0133-0","article-title":"Dose escalation with simultaneous integrated boost (SIB) using volumetric modulated arc therapy (VMAT) in rectal cancer","volume":"50","author":"Alsuhaibani","year":"2019","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijrobp.2007.02.055","article-title":"PET-CT fusion in radiation management of patients with anorectal tumors","volume":"69","author":"Anderson","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.ctro.2025.101014_b0170","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(15)00120-5","article-title":"High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study","volume":"16","author":"Appelt","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2025.101014_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.103206","article-title":"Treatment planning for patients with low rectal cancer in a multicenter prospective organ preservation study","volume":"118","author":"Arp","year":"2024","journal-title":"Phys Med"},{"issue":"6","key":"10.1016\/j.ctro.2025.101014_b0180","first-page":"3201","article-title":"The role of concomitant radiation boost in neoadjuvant chemoradiotherapy for locally advanced rectal cancer","volume":"37","author":"Badakhshi","year":"2017","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0185","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3857\/roj.2017.00353","article-title":"Simultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancer","volume":"35","author":"Bae","year":"2017","journal-title":"Radiat Oncol J"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0190","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024266","article-title":"Dosimetric comparison of organs at risk in 5 different radiotherapy plans in patients with preoperatively irradiated rectal cancer","volume":"100","author":"Bakkal","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0195","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/COC.0b013e318161dbd3","article-title":"Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial","volume":"31","author":"Ballonoff","year":"2008","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2025.101014_b0200","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ijrobp.2007.08.043","article-title":"FDG-PET\/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer","volume":"70","author":"Bassi","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.ctro.2025.101014_b0205","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s11547-020-01189-9","article-title":"A comparative analysis between radiation dose intensification and conventional fractionation in neoadjuvant locally advanced rectal cancer: a monocentric prospective observational study","volume":"125","author":"Bertocchi","year":"2020","journal-title":"Radiol Med"},{"key":"10.1016\/j.ctro.2025.101014_b0210","first-page":"153","article-title":"Online MR guided dose escalated radiotherapy for organ preservation in distal rectal cancer","volume":"37","author":"Boeke","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1515\/raon-2018-0007","article-title":"Preoperative intensity-modulated chemoradiation therapy with simultaneous integrated boost in rectal cancer: 2-year follow-up results of phase II study","volume":"52","author":"But-Hadzic","year":"2018","journal-title":"Radiol Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2025.101014_b0220","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.ijrobp.2008.10.064","article-title":"The role of dual-time combined 18-fluorideoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery","volume":"74","author":"Capirci","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2025.101014_b0225","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1016\/j.prro.2019.12.007","article-title":"Effect and safety of radiation therapy boost to extramesorectal lymph nodes in rectal cancer","volume":"10","author":"Chen","year":"2020","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12672-021-00455-0","article-title":"Radiation boost for synchronous solitary inguinal lymph node metastasis during neoadjuvant chemoradiotherapy for locally advanced rectal cancer","volume":"12","author":"Chen","year":"2021","journal-title":"Discov Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0235","first-page":"3","article-title":"Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancer","volume":"5","author":"Colaco","year":"2014","journal-title":"J Gastrointest Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0240","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00432-019-02881-8","article-title":"Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series","volume":"145","author":"De Bari","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101014_b0245","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/annonc\/mdj041","article-title":"Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study","volume":"17","author":"De Paoli","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2025.101014_b0250","first-page":"24","article-title":"The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer","volume":"36","author":"Devlin","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"issue":"15","key":"10.1016\/j.ctro.2025.101014_b0255","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15153869","article-title":"Preoperative radiotherapy with a simultaneous integrated boost compared to chemoradiotherapy for cT3-4 rectal cancer: long-term results of a multicenter randomized study","volume":"15","author":"Engels","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ctro.2025.101014_b0260","doi-asserted-by":"crossref","first-page":"O66","DOI":"10.1111\/codi.12466","article-title":"Phase II trial of short-course radiotherapy followed by delayed surgery for locoregionally advanced rectal cancer","volume":"16","author":"Faria","year":"2014","journal-title":"Colorectal Dis"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0265","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.radonc.2018.06.019","article-title":"A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer","volume":"128","author":"Fiorino","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101014_b0270","first-page":"99","article-title":"ACO\/ARO\/AIO-21 \u2013 capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer patients: a phase I trial of the German rectal cancer study group","volume":"34","author":"Fleischmann","year":"2022","journal-title":"Clin Transl Rad Oncol"},{"issue":"15","key":"10.1016\/j.ctro.2025.101014_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153665","article-title":"MORPHEUS phase II-III study: a pre-planned interim safety analysis and preliminary results","volume":"14","author":"Garant","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0280","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10456-011-9250-0","article-title":"A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer","volume":"15","author":"Gasparini","year":"2012","journal-title":"Angiogenesis"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0285","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-4040","article-title":"Preliminary results of simultaneous integrated boost intensity-modulated radiation therapy based neoadjuvant chemoradiotherapy on locally advanced rectal cancer with clinically suspected positive lateral pelvic lymph nodes","volume":"9","author":"Geng","year":"2021","journal-title":"Ann Transl Med"},{"issue":"6","key":"10.1016\/j.ctro.2025.101014_b0290","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1200\/JCO.2003.10.045","article-title":"Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial","volume":"21","author":"G\u00e9rard","year":"2003","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101014_b0295","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00259-022-05944-0","article-title":"Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial","volume":"50","author":"Guido","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0300","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.adro.2017.04.001","article-title":"Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: a matched-pair analysis","volume":"2","author":"Gunther","year":"2017","journal-title":"Adv Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0305","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5301\/tj.5000702","article-title":"Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers","volume":"104","author":"Gurdal","year":"2018","journal-title":"Tumori"},{"issue":"6","key":"10.1016\/j.ctro.2025.101014_b0310","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00066-014-0650-0","article-title":"Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation","volume":"190","author":"Hernando-Requejo","year":"2014","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0315","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.ijrobp.2009.12.073","article-title":"Preoperative chemoradiation with irinotecan and capecitabine in patients with locally advanced resectable rectal cancer: long-term results of a phase II study","volume":"79","author":"Hong","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0320","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ijrobp.2007.01.022","article-title":"Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancer","volume":"68","author":"Ho-Pun-Cheung","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.101014_b0325","article-title":"Helical tomotherapy combined with capecitabine in the preoperative treatment of locally advanced rectal cancer","volume":"2014","author":"Huang","year":"2014","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1016\/j.ctro.2025.101014_b0330","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/j.clon.2022.10.008","article-title":"Understanding the benefit of magnetic resonance-guided adaptive radiotherapy in rectal cancer patients: a single-centre study","volume":"35","author":"Ingle","year":"2023","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ctro.2025.101014_b0335","article-title":"Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visits","volume":"2012","author":"Jabbour","year":"2012","journal-title":"Int J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2025.101014_b0340","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3906\/sag-1812-185","article-title":"Neoadjuvant volumetric modulated arc radiochemotherapy with a simultaneous integrated boost technique compared to standard chemoradiation for locally advanced rectal cancer","volume":"49","author":"Jankarashvili","year":"2019","journal-title":"Turkish J Med Sci"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0345","first-page":"1231","article-title":"A comparison of dosimetric and clinical parameters between different IMRT boost techniques in preoperative rectal cancer","volume":"26","author":"Karaca","year":"2021","journal-title":"J BUON"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0350","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3906\/sag-1312-149","article-title":"Is there any impact of PET\/CT on radiotherapy planning in rectal cancer patients undergoing preoperative IMRT?","volume":"45","author":"Kili\u00e7","year":"2015","journal-title":"Turk J Med Sci"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0355","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jjco\/hyv208","article-title":"Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: Implication of boost radiotherapy to the involved mesorectal fascia","volume":"46","author":"Kim","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ctro.2025.101014_b0360","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6986267","article-title":"Simultaneous integrated boost volumetric modulated arc therapy for rectal cancer: long-term results after protocol-based treatment","volume":"2022","author":"Lee","year":"2022","journal-title":"J Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0365","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-022-02182-4","article-title":"The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy for unresectable rectal cancer (SUNRISE): interim analysis of a randomized phase II trial","volume":"17","author":"Liu","year":"2022","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0370","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030921","article-title":"Integrated intensified chemoradiation in the setting of total neoadjuvant therapy (TNT) in patients with locally advanced rectal cancer: a retrospective single-arm study on feasibility and efficacy","volume":"15","author":"Lo Greco","year":"2023","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.ctro.2025.101014_b0375","article-title":"MARC preoperative rectal cancer treatments vs. 3D conformal radiotherapy. A dose distribution comparative study","volume":"14","author":"Luna","year":"2019","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.ctro.2025.101014_b0380","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15235702","article-title":"Preoperative intensified chemoradiation with intensity-modulated radiotherapy and simultaneous integrated boost combined with capecitabine in locally advanced rectal cancer: long-term outcomes of a real-life multicenter study","volume":"15","author":"Lupattelli","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0385","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5301\/tj.5000481","article-title":"Sequential boost in neoadjuvant irradiation for T3N0-1 rectal cancer: long-term results from a single-center experience","volume":"102","author":"Mazzola","year":"2016","journal-title":"Tumori"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0390","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1200\/JCO.2005.03.6095","article-title":"Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012","volume":"24","author":"Mohiuddin","year":"2006","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2025.101014_b0395","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.coc.0000227480.41414.f2","article-title":"Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer","volume":"29","author":"Movsas","year":"2006","journal-title":"Am J Clin Oncol"},{"issue":"31","key":"10.1016\/j.ctro.2025.101014_b0400","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2025.101014_b0405","first-page":"135","article-title":"Successful downstaging of high rectal and recto-sigmoid cancer by neo-adjuvant chemo-radiotherapy","volume":"2","author":"O'Neill","year":"2008","journal-title":"Clin Med Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2025.101014_b0410","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00384-014-1879-x","article-title":"Neoadjuvant chemoradiation with concomitant boost radiotherapy associated to capecitabine in rectal cancer patients","volume":"29","author":"Osti","year":"2014","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0415","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clon.2019.07.009","article-title":"Intensity-modulated radiotherapy with a simultaneous integrated boost in rectal cancer","volume":"32","author":"Owens","year":"2020","journal-title":"Clin Oncol"},{"issue":"5\u20136","key":"10.1016\/j.ctro.2025.101014_b0420","first-page":"137","article-title":"Acute gastrointestinal toxicity and tumor response with preoperative intensity modulated radiation therapy for rectal cancer","volume":"6","author":"Parekh","year":"2013","journal-title":"Gastrointest Cancer Res"},{"issue":"16","key":"10.1016\/j.ctro.2025.101014_b0425","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1002\/cncr.25943","article-title":"Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer","volume":"117","author":"Park","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0430","first-page":"16","article-title":"Preoperative chemoradiation with VMAT-SIB in rectal cancer: a phase II study","volume":"16","author":"Picardi","year":"2017","journal-title":"Clin Colorectal Cancer"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0435","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/0284186X.2012.737022","article-title":"Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients","volume":"52","author":"Radu","year":"2013","journal-title":"Acta Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2025.101014_b0440","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.ijrobp.2011.01.051","article-title":"Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer","volume":"82","author":"Samuelian","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0445","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JCO.20.01740","article-title":"Pre- and postoperative capecitabine without or with oxaliplatin in locally advanced rectal cancer: PETACC 6 trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD","volume":"39","author":"Schmoll","year":"2021","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0450","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa2303269","article-title":"Preoperative treatment of locally advanced rectal cancer","volume":"389","author":"Schrag","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ctro.2025.101014_b0455","first-page":"265","article-title":"Intensified neoadjuvant radio-chemotherapy for locally advanced rectal cancer: mono-istitutional experience and long-term results","volume":"17","author":"Spatola","year":"2019","journal-title":"Int-J-Radiat-Res"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0460","first-page":"147","article-title":"Integral dose and dosimetric comparison of neoadjuvant simultaneous integrated boost (SIB) radiotherapy technique for rectal cancer using intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), and helical tomotherapy (HT)","volume":"29","author":"Temelli","year":"2019","journal-title":"UHOD \u2013 Uluslararasi Hematoloji-Onkoloji Dergisi"},{"issue":"35","key":"10.1016\/j.ctro.2025.101014_b0465","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.3748\/wjg.v16.i35.4436","article-title":"High-dose-rate intraluminal brachytherapy during preoperative chemoradiation for locally advanced rectal cancers","volume":"16","author":"Tunio","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ctro.2025.101014_b0470","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065010","article-title":"Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial","volume":"13","author":"Verweij","year":"2023","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0475","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/0284186X.2011.652740","article-title":"High-dose radiotherapy (60 Gy) with oral UFT\/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase i trial","volume":"51","author":"Vestermark","year":"2012","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0480","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.radonc.2018.04.004","article-title":"Preoperative radiotherapy and local excision of rectal cancer: long-term results of a randomised study","volume":"127","author":"Wawok","year":"2018","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0485","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.prro.2013.09.002","article-title":"Clinical utility of integrated positron emission tomography\/computed tomography imaging in the clinical management and radiation treatment planning of locally advanced rectal cancer","volume":"4","author":"Whaley","year":"2014","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101014_b0490","first-page":"3614","article-title":"Effect of concurrent radiotherapy and simultaneous oral capecitabine chemotherapy on locally advanced middle and lower rectal cancer","volume":"9","author":"Xu","year":"2016","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0495","first-page":"1","article-title":"Sequential simulation computed tomography allows assessment of internal rectal movements during preoperative chemoradiotherapy in rectal cancer","volume":"15","author":"Yang","year":"2019","journal-title":"J Cancer Res Ther"},{"issue":"5","key":"10.1016\/j.ctro.2025.101014_b0500","doi-asserted-by":"crossref","first-page":"557","DOI":"10.7785\/tcrt.2012.500442","article-title":"A dosimetric analysis of preoperative intensity-modulated and image-guided radiation therapy with and without simultaneous integrated boost for locally advanced rectal cancer","volume":"14","author":"Yang","year":"2015","journal-title":"Technol Cancer Res Treatment"},{"key":"10.1016\/j.ctro.2025.101014_b0505","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818824367","article-title":"Preoperative volumetric modulated arc therapy with simultaneous integrated boost for locally advanced distal rectal cancer","volume":"18","author":"Yang","year":"2019","journal-title":"Technol Cancer Res Treatment"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0510","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025944","article-title":"Dose escalation of preoperative short-course radiotherapy followed by neoadjuvant chemotherapy in locally advanced rectal cancer: protocol for an open-label, single-centre, phase i clinical trial","volume":"9","author":"Zhang","year":"2019","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.ctro.2025.101014_b0515","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.18632\/oncotarget.6401","article-title":"Dosimetric comparisons of VMAT, IMRT and 3DCRT for locally advanced rectal cancer with simultaneous integrated boost","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctro.2025.101014_b0520","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2147\/CMAR.S193657","article-title":"Concomitant dose escalation with image-guided tomotherapy in locally advanced mid\u2013low rectal cancer: a single-center study","volume":"11","author":"Zhao","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0525","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13014-020-01738-6","article-title":"Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer","volume":"16","author":"Zhao","year":"2021","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0530","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.21873\/invivo.11896","article-title":"Treatment intensification for locally advanced rectal cancer: impact on pathological complete response and outcomes","volume":"34","author":"Di Tommaso","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.ctro.2025.101014_b0535","doi-asserted-by":"crossref","unstructured":"Morgan-Fletcher SL. Prescribing, recording and reporting photon beam therapy (supplement to ICRU Report 50), ICRU Report 62. ICRU, pp. ix+52, 1999 (ICRU Bethesda, MD) $65.00 ISBN 0-913394-61-0. Brit J Radiol 2001;74(879):294.","DOI":"10.1259\/bjr.74.879.740294"},{"issue":"7","key":"10.1016\/j.ctro.2025.101014_b0540","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1200\/JCO.2002.07.132","article-title":"Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control\u2013final report of intergroup 0114","volume":"20","author":"Tepper","year":"2002","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2025.101014_b0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221262","article-title":"mARC preoperative rectal cancer treatments vs. 3D conformal radiotherapy. A dose distribution comparative study","volume":"14","author":"Berm\u00fadez Luna","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0550","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1748-717X-5-17","article-title":"Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications","volume":"5","author":"Arbea","year":"2010","journal-title":"Radiat Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2025.101014_b0555","article-title":"A retrospective comparison of toxicity, response and survival of intensity-modulated radiotherapy versus three-dimensional conformal radiation therapy in the treatment of rectal carcinoma","volume":"15","author":"Kouklidis","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094456","article-title":"Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers","volume":"9","author":"Spiotto","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ctro.2025.101014_b0565","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejmp.2020.04.012","article-title":"Dosimetric and radiobiological comparison of simultaneous integrated boost and sequential boost of locally advanced cervical cancer","volume":"73","author":"Sukhikh","year":"2020","journal-title":"Phys Med"},{"issue":"12","key":"10.1016\/j.ctro.2025.101014_b0570","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00066-015-0888-1","article-title":"Simultaneous integrated vs. sequential boost in VMAT radiotherapy of high-grade gliomas","volume":"191","author":"Farzin","year":"2015","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"10.1016\/j.ctro.2025.101014_b0575","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ijrobp.2020.12.005","volume":"109","author":"H\u00f6rner-Rieber","year":"2021","journal-title":"Int J Rad Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0580","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13014-018-1124-9","article-title":"Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study","volume":"13","author":"Franco","year":"2018","journal-title":"Radiat Oncol"},{"issue":"740","key":"10.1016\/j.ctro.2025.101014_b0585","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2025.101014_b0590","article-title":"Benefits of adopting hypofractionated radiotherapy as a standard of care in low-and middle-income countries","volume":"8","author":"Kraus","year":"2022","journal-title":"JCO Glob Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0595","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ijrobp.2004.11.015","article-title":"Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients","volume":"62","author":"Kim","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2025.101014_b0600","article-title":"Optimization of field design in the treatment of rectal cancer with intensity modulated proton beam radiation therapy: how many fields are needed to account for rectal distension uncertainty?","volume":"6","author":"Parzen","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101014_b0605","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1017\/S1460396919000530","article-title":"Overview of patient preparation strategies to manage internal organ motion during radiotherapy in the pelvis","volume":"19","author":"Slevin","year":"2020","journal-title":"J Radiother Pract"},{"issue":"6","key":"10.1016\/j.ctro.2025.101014_b0610","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.prro.2014.06.005","article-title":"A systematic review: effectiveness of rectal emptying preparation in prostate cancer patients","volume":"4","author":"McNair","year":"2014","journal-title":"Pract Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0615","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clon.2013.11.031","article-title":"A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer","volume":"26","author":"Jadon","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0620","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.radonc.2012.02.013","article-title":"Adaptive radiotherapy for long course neo-adjuvant treatment of rectal cancer","volume":"103","author":"Nijkamp","year":"2012","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0625","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13014-021-01866-7","article-title":"Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer","volume":"16","author":"de Jong","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101014_b0630","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2020.09.024","article-title":"Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience","volume":"154","author":"Intven","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101014_b0635","article-title":"Investigation of changes in planning target volume and regression probability of rectal boost using in-silico cone-beam computed tomography-guided online-adaptive radiotherapy","volume":"34","author":"Pierrard","year":"2025","journal-title":"Phys Imaging Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101014_b0640","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.radonc.2009.08.007","article-title":"Target volume shape variation during irradiation of rectal cancer patients in supine position: comparison with prone position","volume":"93","author":"Nijkamp","year":"2009","journal-title":"Radiother Oncol"},{"issue":"976","key":"10.1016\/j.ctro.2025.101014_b0645","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1259\/bjr\/57848689","article-title":"The effect of treatment position, prone or supine, on dose-volume histograms for pelvic radiotherapy in patients with rectal cancer","volume":"82","author":"Drzymala","year":"2009","journal-title":"Br J Radiol"},{"issue":"7","key":"10.1016\/j.ctro.2025.101014_b0650","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1080\/02841860802304564","article-title":"Image-guidance protocol comparison: supine and prone set-up accuracy for pelvic radiation therapy","volume":"47","author":"Siddiqui","year":"2008","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2025.101014_b0655","doi-asserted-by":"crossref","unstructured":"Gr\u00e9goire V, Mackie TR. State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83). Cancer\/Radioth\u00e9r 2011;15(6):555\u2013559.","DOI":"10.1016\/j.canrad.2011.04.003"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0660","doi-asserted-by":"crossref","first-page":"W42","DOI":"10.2214\/AJR.14.14201","article-title":"MRI of rectal cancer: an overview and update on recent advances","volume":"205","author":"Jhaveri","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0665","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ijrobp.2006.02.050","article-title":"Definition and delineation of the clinical target volume for rectal cancer","volume":"65","author":"Roels","year":"2006","journal-title":"Int J Rad Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0670","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1016\/j.ijrobp.2011.03.031","article-title":"Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET\/CT: a prospective study","volume":"81","author":"Br\u00e6ndengen","year":"2011","journal-title":"Int J Rad Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2025.101014_b0675","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.radonc.2011.12.016","article-title":"FDG-PET-CT reduces the interobserver variability in rectal tumor delineation","volume":"102","author":"Buijsen","year":"2012","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0680","doi-asserted-by":"crossref","first-page":"424","DOI":"10.21873\/invivo.13095","article-title":"DWI-MR and PET-CT functional imaging for boost tumor volume delineation in neoadjuvant rectal cancer treatment","volume":"37","author":"Rosa","year":"2023","journal-title":"In Vivo"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0685","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041009","article-title":"Online adaptive MRI-guided radiotherapy for primary tumor and lymph node boosting in rectal cancer","volume":"15","author":"Kensen","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0690","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/j.ijrobp.2011.04.060","article-title":"Quantification of organ motion during chemoradiotherapy of rectal cancer using cone-beam computed tomography","volume":"81","author":"Chong","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2025.101014_b0695","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/0284186X.2018.1532598","article-title":"MRI-based tumor inter-fraction motion statistics for rectal cancer boost radiotherapy","volume":"58","author":"Kleijnen","year":"2019","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.101014_b0700","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2011.05.068","article-title":"Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer","volume":"83","author":"Engels","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl_4","key":"10.1016\/j.ctro.2025.101014_b0705","doi-asserted-by":"crossref","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones","year":"2017","journal-title":"Ann Oncol"},{"issue":"29","key":"10.1016\/j.ctro.2025.101014_b0710","doi-asserted-by":"crossref","first-page":"45513","DOI":"10.18632\/oncotarget.9995","article-title":"Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: an updated systematic review and meta-analysis","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.ctro.2025.101014_b0715","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv248","article-title":"Neoadjuvant 5-FU or capecitabine plus radiation with or without oxaliplatin in rectal cancer patients: a phase III randomized clinical trial","volume":"107","author":"Allegra","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.ctro.2025.101014_b0720","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1470-2045(15)00159-X","article-title":"Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO\/ARO\/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial","volume":"16","author":"R\u00f6del","year":"2015","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2025.101014_b0725","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2009.25.8376","article-title":"Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12\/0405-Prodige 2","volume":"28","author":"G\u00e9rard","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101014_b0730","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1245\/s10434-015-5017-y","article-title":"Predictors of pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer","volume":"23","author":"Al-Sukhni","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ctro.2025.101014_b0735","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2025.101014_b0740","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/bjs.8702","article-title":"Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer","volume":"99","author":"Martin","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.ctro.2025.101014_b0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctarc.2022.100540","article-title":"Clinico-pathological predictors of clinical complete response in rectal cancer","volume":"31","author":"Mbanu","year":"2022","journal-title":"Cancer Treatment Res Commun"},{"issue":"2","key":"10.1016\/j.ctro.2025.101014_b0750","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.radonc.2014.11.026","article-title":"The role of diffusion-weighted MRI and 18F-FDG PET\/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review","volume":"113","author":"Joye","year":"2014","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2025.101014_b0755","doi-asserted-by":"crossref","DOI":"10.1097\/DCR.0b013e3182837e5b","article-title":"Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer","volume":"56","author":"Huh","year":"2013","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.ctro.2025.101014_b0760","first-page":"56","article-title":"Can we reliably predict a clinical complete response in rectal cancer? Current trends and future strategies","volume":"14","author":"Taveras","year":"2018","journal-title":"Curr Colorectal Cancer Rep"},{"issue":"22","key":"10.1016\/j.ctro.2025.101014_b0765","doi-asserted-by":"crossref","first-page":"33374","DOI":"10.18632\/oncotarget.8133","article-title":"Clinical predictive factors of pathologic complete response in locally advanced rectal cancer","volume":"7","author":"De Felice","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctro.2025.101014_b0770","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:14:34Z","timestamp":1772766874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630825001065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":154,"alternative-id":["S2405630825001065"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101014","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy boost to the primary tumour in locally advanced rectal cancer: Systematic review of practices and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101014"}}